Latest PAD News & Research


EXCITE ISR Achieves Statistical Endpoint; 501(k) Application on its Way -- February 28, 2014

Spectranetics has achieved statistical significance with respect to their 30-day freedom from major adverse event endpoint for the EXCITE ISR trial, which compared standard balloon angioplasty to angioplasty plus laser atherectomy. The company anticipates submitting the 501(k) application for FDA-approvement of the laser atherectomy device...Read More

Boston Scientific Launches OffRoad Re-entry Catheter System -- February 5, 2014

Due to favorable results of the RE-ROUTE clinical trial, Boston Scientific has decided to launch the unique re-entry catheter, which uses a conical-shaped positioning balloon to help direct a microcatheter to re-enter the vessel lumen ... Read More

Review of Atherectomy in the Peripheral Vessels -- January 28, 2014

This review paper amasses data from two randomized trials along with several registry and single-arm studies, and studies atherectomy usage as a stand-alone and in conjuctive therapy in infrainguinal arterial disease ...Read More (no link)

Outback Re-Entry Catheter Usage in Infrainguinal Arteries -- November 11, 2013

51 patients between 2004 and 2009 who were treated with the Outback LTD Re-Entry Catheter were retrospectively analyzed, and all but two cases achieved procedural success with only 1 procedural complication. The Outback LTD Catheter is a safe and effective tool for infrainguinal artery revascularization...Read More